Compare PGEN & VERX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | VERX |
|---|---|---|
| Founded | 1998 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | 2013 | 2020 |
| Metric | PGEN | VERX |
|---|---|---|
| Price | $4.21 | $17.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 15 |
| Target Price | $13.67 | ★ $20.85 |
| AVG Volume (30 Days) | ★ 6.8M | 1.4M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | $230,981,000.00 | ★ $748,444,000.00 |
| Revenue This Year | $2,380.31 | $10.85 |
| Revenue Next Year | $84.01 | $10.46 |
| P/E Ratio | ★ $34.63 | $302.25 |
| Revenue Growth | N/A | ★ 12.25 |
| 52 Week Low | $3.04 | $10.21 |
| 52 Week High | $8.98 | $20.82 |
| Indicator | PGEN | VERX |
|---|---|---|
| Relative Strength Index (RSI) | 31.74 | 61.96 |
| Support Level | $3.89 | $10.89 |
| Resistance Level | $4.41 | $18.53 |
| Average True Range (ATR) | 0.36 | 0.73 |
| MACD | -0.01 | -0.10 |
| Stochastic Oscillator | 16.78 | 63.84 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Vertex Inc is a provider of tax technology and services. Its software, content, and services help customers stay in compliance with indirect taxes that occur in taxing jurisdictions all over the world. It provides cloud-based and on-premise solutions to specific industries for every line of tax, including income, sales, consumer use, value-added, and payroll. The company offers solutions such as tax determination, Tax Data Management, document management, and compliance and reporting, among others. The company derives revenue from software subscriptions.